Target Name: ASB4
NCBI ID: G51666
Review Report on ASB4 Target / Biomarker Content of Review Report on ASB4 Target / Biomarker
ASB4
Other Name(s): Ankyrin repeat and SOCS box containing 4, transcript variant 1 | ASB-4 | ASB4_HUMAN | ASB4 variant 1 | ankyrin repeat and SOCS box containing 4 | Ankyrin repeat and SOCS box-containing 4 | Ankyrin repeat and SOCS box protein 4 | Ankyrin repeat and SOCS box protein 4 (isoform a)

Understanding ASB4: A Potential Drug Target and Biomarker

ASB4, also known as Ankyrin repeat and SOCS box containing 4, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is found in various tissues and cell types in the human body, including the brain, heart, liver, and muscle.

ASB4 is made up of four exons that are repeated in a specific order. The first exon has a single nucleotide, while the second exon has a double nucleotide. The third and fourth exons have double nucleotides. This repeated sequence is thought to be a key feature that defines ASB4.

ASB4 has been shown to play a role in various biological processes in the body. For example, it has been shown to be involved in the regulation of gene expression, particularly in the brain. Studies have also shown that ASB4 is involved in the development and progression of various diseases, including cancer.

ASB4 has also been identified as a potential drug target. Its repetitive nature and its involvement in various biological processes make it an attractive target for drug developers. Studies have shown that ASB4 can be targeted with small molecules, such as inhibitors, to reduce its expression and prevent it from participating in certain cellular processes.

In addition to its potential as a drug target, ASB4 has also been shown to be a potential biomarker. Its repetitive nature makes it easy to detect and measure, which can be useful for tracking the effectiveness of drugs. Studies have shown that ASB4 levels can be reliably measured in various biological samples, including blood, urine, and tissue samples.

ASB4 has also been shown to be involved in the regulation of cellular processes that are important for human health. For example, it has been shown to be involved in the regulation of cell division, which is important for the growth and development of tissues and organs. It has also been shown to be involved in the regulation of cell death, which is important for maintaining tissue homeostasis and preventing disease.

In conclusion, ASB4 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its repetitive nature and its involvement in various biological processes make it an attractive target for drug developers. Studies have also shown that ASB4 can be used as a biomarker for tracking the effectiveness of drugs and for identifying potential drug targets. Further research is needed to fully understand the role of ASB4 in various biological processes and to develop effective drugs and biomarkers for it.

Protein Name: Ankyrin Repeat And SOCS Box Containing 4

Functions: Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Promotes differentiation and maturation of the vascular lineage by an oxygen-dependent mechanism (By similarity)

The "ASB4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ASB4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ASB5 | ASB6 | ASB7 | ASB8 | ASB9 | ASB9P1 | ASCC1 | ASCC2 | ASCC3 | ASCL1 | ASCL3 | ASCL4 | ASCL5 | ASF1A | ASF1B | ASGR1 | ASGR2 | ASH1L | ASH1L-AS1 | ASH2L | Asialoglycoprotein receptor | Asialoglycoprotein Receptor (ASGPR) | ASIC1 | ASIC2 | ASIC3 | ASIC4 | ASIC5 | ASIP | ASL | ASMER1 | ASMER2 | ASMT | ASMTL | ASMTL-AS1 | ASNS | ASNSD1 | ASNSP1 | ASPA | ASPDH | ASPG | ASPH | ASPHD1 | ASPHD2 | ASPM | ASPN | ASPRV1 | ASPSCR1 | ASRGL1 | ASS1 | ASS1P1 | ASS1P10 | ASS1P11 | ASS1P12 | ASS1P13 | ASS1P2 | ASS1P4 | ASS1P5 | ASS1P6 | ASS1P7 | ASS1P9 | ASTE1 | ASTL | ASTN1 | ASTN2 | ASTN2-AS1 | Astrin complex | ASXL1 | ASXL2 | ASXL3 | ASZ1 | AT-Rich interactive domain-containing protein | ATAD1 | ATAD2 | ATAD2B | ATAD3A | ATAD3B | ATAD3C | ATAD5 | ATAT1 | ATCAY | ATE1 | ATE1-AS1 | ATF1 | ATF2 | ATF3 | ATF4 | ATF4P2 | ATF4P4 | ATF5 | ATF6 | ATF6-DT | ATF6B | ATF7 | ATF7IP | ATF7IP2 | ATG10 | ATG101 | ATG12 | ATG13 | ATG14